<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36139092</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2218-273X</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>07</Day></PubDate></JournalIssue><Title>Biomolecules</Title><ISOAbbreviation>Biomolecules</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 Invasion and Pathological Links to Prion Disease.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1253</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biom12091253</ELocationID><Abstract><AbstractText>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the COVID-19 disease, is a highly infectious and transmissible viral pathogen that continues to impact human health globally. Nearly ~600 million people have been infected with SARS-CoV-2, and about half exhibit some degree of continuing health complication, generically referred to as long COVID. Lingering and often serious neurological problems for patients in the post-COVID-19 recovery period include brain fog, behavioral changes, confusion, delirium, deficits in intellect, cognition and memory issues, loss of balance and coordination, problems with vision, visual processing and hallucinations, encephalopathy, encephalitis, neurovascular or cerebrovascular insufficiency, and/or impaired consciousness. Depending upon the patient&#x2019;s age at the onset of COVID-19 and other factors, up to ~35% of all elderly COVID-19 patients develop a mild-to-severe encephalopathy due to complications arising from a SARS-CoV-2-induced cytokine storm and a surge in cytokine-mediated pro-inflammatory and immune signaling. In fact, this cytokine storm syndrome: (i) appears to predispose aged COVID-19 patients to the development of other neurological complications, especially those who have experienced a more serious grade of COVID-19 infection; (ii) lies along highly interactive and pathological pathways involving SARS-CoV-2 infection that promotes the parallel development and/or intensification of progressive and often lethal neurological conditions, and (iii) is strongly associated with the symptomology, onset, and development of human prion disease (PrD) and other insidious and incurable neurological syndromes. This commentary paper will evaluate some recent peer-reviewed studies in this intriguing area of human SARS-CoV-2-associated neuropathology and will assess how chronic, viral-mediated changes to the brain and CNS contribute to cognitive decline in PrD and other progressive, age-related neurodegenerative disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lukiw</LastName><ForeName>Walter J</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>LSU Neuroscience Center, Louisiana State University Health Science Center, New Orleans, LA 70112, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alchem Biotek Research, Toronto, ON M5S 1A8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology, LSU Health Science Center, New Orleans, LA 70112, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department Neurology, LSU Health Science Center, New Orleans, LA 70112, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaber</LastName><ForeName>Vivian R</ForeName><Initials>VR</Initials><AffiliationInfo><Affiliation>LSU Neuroscience Center, Louisiana State University Health Science Center, New Orleans, LA 70112, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pogue</LastName><ForeName>Aileen I</ForeName><Initials>AI</Initials><AffiliationInfo><Affiliation>Alchem Biotek Research, Toronto, ON M5S 1A8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yuhai</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>LSU Neuroscience Center, Louisiana State University Health Science Center, New Orleans, LA 70112, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell Biology &amp; Anatomy, LSU Health Science Center, New Orleans, LA 70112, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG018031</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG038834</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG038834</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG18031</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomolecules</MedlineTA><NlmUniqueID>101596414</NlmUniqueID><ISSNLinking>2218-273X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000080424" MajorTopicYN="N">Cytokine Release Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004660" MajorTopicYN="Y">Encephalitis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="Y">Nervous System Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017096" MajorTopicYN="Y">Prion Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Creutzfeldt&#x2013;Jakob disease (CJD)</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">angiotensin-converting enzyme 2 receptor (ACE2R)</Keyword><Keyword MajorTopicYN="N">cytokine storm</Keyword><Keyword MajorTopicYN="N">miRNA-146a</Keyword><Keyword MajorTopicYN="N">miRNA-155</Keyword><Keyword MajorTopicYN="N">microRNA (miRNA)</Keyword><Keyword MajorTopicYN="N">prion disease (PrD)</Keyword></KeywordList><CoiStatement>The authors declare that the research work in this commentary paper was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>23</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36139092</ArticleId><ArticleId IdType="pmc">PMC9496025</ArticleId><ArticleId IdType="doi">10.3390/biom12091253</ArticleId><ArticleId IdType="pii">biom12091253</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mao L., Jin H., Wang M., Hu Y., Chen S., He Q. Neurologic manifestations of hospitalized patients with coronavirus dis-ease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683&#x2013;690. doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Danics K., Forrest S.L., Kapas I., Erber I., Schmid S., T&#xf6;r&#x151; K., Majtenyi K., Kovacs G.G. Neurodegenerative proteinopathies associated with neuroinfections. J. Neural Transm. 2021;128:1551&#x2013;1566. doi: 10.1007/s00702-021-02371-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-021-02371-7</ArticleId><ArticleId IdType="pmc">PMC8255726</ArticleId><ArticleId IdType="pubmed">34223998</ArticleId></ArticleIdList></Reference><Reference><Citation>Idrees D., Kumar V. SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration. Biochem. Biophys. Res. Commun. 2021;554:94&#x2013;98. doi: 10.1016/j.bbrc.2021.03.100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2021.03.100</ArticleId><ArticleId IdType="pmc">PMC7988450</ArticleId><ArticleId IdType="pubmed">33789211</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigasova D., Nemergut M., Liskova B., Damborsky J. Multi-pathogen infections and Alzheimer&#x2019;s disease. Microb. Cell Factories. 2021;20:1&#x2013;13. doi: 10.1186/s12934-021-01520-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12934-021-01520-7</ArticleId><ArticleId IdType="pmc">PMC7844946</ArticleId><ArticleId IdType="pubmed">33509204</ArticleId></ArticleIdList></Reference><Reference><Citation>Lingor P., Demleitner A.F., Wolff A.W., Feneberg E. SARS-CoV-2 and neurodegenerative diseases: What we know and what we don&#x2019;t. J. Neural Transm. 2022:1&#x2013;13. doi: 10.1007/s00702-022-02500-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-022-02500-w</ArticleId><ArticleId IdType="pmc">PMC9013492</ArticleId><ArticleId IdType="pubmed">35434769</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukiw W.J. David Hunter Hubel, the &#x2018;Circe effect&#x2019;, and SARS-CoV-2 infection of the human visual system. Front. Biosci. 2022;27:7. doi: 10.31083/j.fbl2701007.</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.fbl2701007</ArticleId><ArticleId IdType="pubmed">35090312</ArticleId></ArticleIdList></Reference><Reference><Citation>Piekut T., Hur&#x142;a M., Banaszek N., Szejn P., Dorszewska J., Kozubski W., Prendecki M. Infectious agents and Alzheimer&#x2019;s disease. J. Integr. Neurosci. 2022;21:73. doi: 10.31083/j.jin2102073.</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.jin2102073</ArticleId><ArticleId IdType="pubmed">35364661</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirin S., Dolanbay S.N., Aslim B. The relationship of early- and late-onset Alzheimer&#x2019;s disease genes with COVID-19. J. Neural Transm. 2022;129:847&#x2013;859. doi: 10.1007/s00702-022-02499-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-022-02499-0</ArticleId><ArticleId IdType="pmc">PMC9012910</ArticleId><ArticleId IdType="pubmed">35429259</ArticleId></ArticleIdList></Reference><Reference><Citation>Szabo M.P., Iba M., Nath A., Masliah E., Kim C. Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS. Exp. Mol. Med. 2022;54:447&#x2013;454. doi: 10.1038/s12276-022-00755-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-022-00755-7</ArticleId><ArticleId IdType="pmc">PMC8990637</ArticleId><ArticleId IdType="pubmed">35396576</ArticleId></ArticleIdList></Reference><Reference><Citation>Ball M.J., Lukiw W.J., Kammerman E.M., Hill J.M. Intracerebral propagation of Alzheimer&#x2019;s disease: Strengthening evidence of a herpes simplex virus etiology. Alzheimer&#x2019;s Dement. 2013;9:169&#x2013;175. doi: 10.1016/j.jalz.2012.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2012.07.005</ArticleId><ArticleId IdType="pmc">PMC3578985</ArticleId><ArticleId IdType="pubmed">23159044</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad K.N., Bondy S.C. Oxidative and Inflammatory Events in Prion Diseases: Can They Be Therapeutic Targets? Curr. Aging Sci. 2019;11:216&#x2013;225. doi: 10.2174/1874609812666190111100205.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874609812666190111100205</ArticleId><ArticleId IdType="pmc">PMC6635421</ArticleId><ArticleId IdType="pubmed">30636622</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseini S., Michaelsen-Preusse K., Schughart K., Korte M. Long-Term Consequence of Non-neurotropic H3N2 Influenza A Virus Infection for the Progression of Alzheimer&#x2019;s Disease Symptoms. Front. Cell. Neurosci. 2021;15:643650. doi: 10.3389/fncel.2021.643650.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.643650</ArticleId><ArticleId IdType="pmc">PMC8113629</ArticleId><ArticleId IdType="pubmed">33994946</ArticleId></ArticleIdList></Reference><Reference><Citation>Pogue A.I., Lukiw W.J. microRNA-146a-5p, Neurotropic Viral Infection and Prion Disease (PrD) Int. J. Mol. Sci. 2021;22:9198. doi: 10.3390/ijms22179198.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22179198</ArticleId><ArticleId IdType="pmc">PMC8431499</ArticleId><ArticleId IdType="pubmed">34502105</ArticleId></ArticleIdList></Reference><Reference><Citation>Choe K., Park H.Y., Ikram M., Lee H.J., Park T.J., Ullah R., Kim M.O. Systematic Review of the Common Pathophysiological Mechanisms in COVID-19 and Neurodegeneration: The Role of Bioactive Compounds and Natural Antioxidants. Cells. 2022;11:1298. doi: 10.3390/cells11081298.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11081298</ArticleId><ArticleId IdType="pmc">PMC9031507</ArticleId><ArticleId IdType="pubmed">35455977</ArticleId></ArticleIdList></Reference><Reference><Citation>Carta M., Aguzzi A. Molecular foundations of prion strain diversity. Curr. Opin. Neurobiol. 2022;72:22&#x2013;31. doi: 10.1016/j.conb.2021.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2021.07.010</ArticleId><ArticleId IdType="pubmed">34416480</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.-E., Choi H., Shin N., Kong D., Kim N.G., Kim H.-Y., Kim M.-J., Choi S.W., Kim Y.B., Kang K.-S. Zika virus infection accelerates Alzheimer&#x2019;s disease phenotypes in brain organoids. Cell Death Discov. 2022;8:1&#x2013;10. doi: 10.1038/s41420-021-00796-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-021-00796-3</ArticleId><ArticleId IdType="pmc">PMC8976422</ArticleId><ArticleId IdType="pubmed">35368019</ArticleId></ArticleIdList></Reference><Reference><Citation>Naeimi W.R., Serio T.R. Beyond Amyloid Fibers: Accumulation, Biological Relevance, and Regulation of Higher-Order Prion Architectures. Viruses. 2022;14:1635. doi: 10.3390/v14081635.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14081635</ArticleId><ArticleId IdType="pmc">PMC9332770</ArticleId><ArticleId IdType="pubmed">35893700</ArticleId></ArticleIdList></Reference><Reference><Citation>Protto V., Marcocci M.E., Miteva M.T., Piacentini R., Puma D.D.L., Grassi C., Palamara A.T., De Chiara G. Role of HSV-1 in Alzheimer&#x2019;s disease pathogenesis: A challenge for novel preventive/therapeutic strategies. Curr. Opin. Pharmacol. 2022;63:102200. doi: 10.1016/j.coph.2022.102200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2022.102200</ArticleId><ArticleId IdType="pubmed">35276497</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlson G.A., Prusiner S.B. How an infection of sheep revealed prion mechanisms in Alzheimer&#x2019;s disease and other neu-rodegenerative disorders. Int. J. Mol. Sci. 2021;22:4861. doi: 10.3390/ijms22094861.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22094861</ArticleId><ArticleId IdType="pmc">PMC8125442</ArticleId><ArticleId IdType="pubmed">34064393</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers J.I., Paras N.A., Prusiner S.B. Expanding spectrum of prion diseases. Emerg. Top. Life Sci. 2020;4:155&#x2013;167. doi: 10.1042/etls20200037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/etls20200037</ArticleId><ArticleId IdType="pubmed">32803268</ArticleId></ArticleIdList></Reference><Reference><Citation>Horn A., Krist L., Lieb W., Montellano F.A., Kohls M., Haas K., Gelbrich G., Bolay-Gehrig S.J., Morbach C., Reese J.P., et al. Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: Design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP) Infection. 2021;49:1277&#x2013;1287. doi: 10.1007/s15010-021-01707-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01707-5</ArticleId><ArticleId IdType="pmc">PMC8508400</ArticleId><ArticleId IdType="pubmed">34642875</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes C., Cunningham C., Zotova E., Culliford D., Perry V.H. Proinflammatory cytokines, sickness behavior, and Alzheimer disease. Neurology. 2011;77:212&#x2013;218. doi: 10.1212/WNL.0b013e318225ae07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318225ae07</ArticleId><ArticleId IdType="pmc">PMC3136056</ArticleId><ArticleId IdType="pubmed">21753171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S.W., Rane N.S., Kim S.J., Garrison J.L., Taunton J., Hegde R.S. SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2. Cell. 2020;183:1043&#x2013;1057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489987</ArticleId><ArticleId IdType="pubmed">32970989</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan L., Zheng Q., Zhang H., Niu Y., Lou Y., Wang H. The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens. Front. Immunol. 2020;11:576622. doi: 10.3389/fimmu.2020.576622.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.576622</ArticleId><ArticleId IdType="pmc">PMC7575906</ArticleId><ArticleId IdType="pubmed">33117378</ArticleId></ArticleIdList></Reference><Reference><Citation>Palacios-R&#xe1;palo S.N., De Jes&#xfa;s-Gonz&#xe1;lez L.A., Cordero-Rivera C.D., Farfan-Morales C.N., Osuna-Ramos J.F., Mart&#xed;nez-Mier G., Quisti&#xe1;n-Galv&#xe1;n J., Mu&#xf1;oz-P&#xe9;rez A., Bernal-Dolores V., del &#xc1;ngel R.M., et al. Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry. Front. Immunol. 2021;12:796855. doi: 10.3389/fimmu.2021.796855.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.796855</ArticleId><ArticleId IdType="pmc">PMC8719300</ArticleId><ArticleId IdType="pubmed">34975904</ArticleId></ArticleIdList></Reference><Reference><Citation>Piras M., Cau F., Manchia M., Paribello P., Saba L., Suri J.S., Gerosa C. Strong ACE-2 expression in the choroidal vessels: Do high choroid plexuses serve as a gateway for SARS-CoV-2 infection on the human brain? Eur. Rev. Med. Pharmacol. Sci. 2022;26:3025&#x2013;3029. doi: 10.26355/eurrev_202204_28633.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202204_28633</ArticleId><ArticleId IdType="pubmed">35503602</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M.-Y., Zhao R., Gao L.-J., Gao X.-F., Wang D.-P., Cao J.-M. SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development. Front. Cell. Infect. Microbiol. 2020;10:587269. doi: 10.3389/fcimb.2020.587269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.587269</ArticleId><ArticleId IdType="pmc">PMC7723891</ArticleId><ArticleId IdType="pubmed">33324574</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T., Cao Y., Zhang H., Wang Z., Man C.H., Yang Y., Chen L., Xu S., Yan X., Zheng Q., et al. COVID-19 metabolism: Mechanisms and therapeutic targets. MedComm. 2022;3:e157. doi: 10.1002/mco2.157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mco2.157</ArticleId><ArticleId IdType="pmc">PMC9363584</ArticleId><ArticleId IdType="pubmed">35958432</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill J.M., Clement C., Arceneaux L., Lukiw W.J. Angiotensin converting enzyme 2 (ACE2) expression in the aged brain and visual system. J. Aging. Sci. 2021;9((Suppl. S7)) doi: 10.21203/rs.3.rs-296818/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-296818/v1</ArticleId><ArticleId IdType="pmc">PMC8580311</ArticleId><ArticleId IdType="pubmed">34765681</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Li W., Lukiw W. Ubiquity of the SARS-CoV-2 receptor ACE2 and upregulation in limbic regions of Alzheimer&#x2019;s disease brain. Folia Neuropathol. 2021;59:232&#x2013;238. doi: 10.5114/fn.2021.109495.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/fn.2021.109495</ArticleId><ArticleId IdType="pubmed">34628788</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirtipal N., Kumar S., Dubey S.K., Dwivedi V.D., Babu K.G., Mal&#xfd; P., Bharadwaj S. Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage. Infect. Genet. Evol. 2022;99:105254. doi: 10.1016/j.meegid.2022.105254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2022.105254</ArticleId><ArticleId IdType="pmc">PMC8863418</ArticleId><ArticleId IdType="pubmed">35217145</ArticleId></ArticleIdList></Reference><Reference><Citation>Hixon A.M., Thaker A.A., Pelak V.S. Persistent visual dysfunction following posterior reversible encephalopathy syndrome due to COVID-19: Case series and literature review. Eur. J. Neurol. 2021;28:3289&#x2013;3302. doi: 10.1111/ene.14965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14965</ArticleId><ArticleId IdType="pmc">PMC8444757</ArticleId><ArticleId IdType="pubmed">34115917</ArticleId></ArticleIdList></Reference><Reference><Citation>Molina-Molina M., Hern&#xe1;ndez-Argudo M. Respiratory consequences after COVID-19: Outcome and treatment. Rev. Esp. Quim. 2022;35:67&#x2013;72. doi: 10.37201/req/s01.16.2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.37201/req/s01.16.2022</ArticleId><ArticleId IdType="pmc">PMC9106190</ArticleId><ArticleId IdType="pubmed">35488831</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercatelli D., Giorgi F.M. Geographic and Genomic Distribution of SARS-CoV-2 Mutations. Front. Microbiol. 2020;11:1800. doi: 10.3389/fmicb.2020.01800.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01800</ArticleId><ArticleId IdType="pmc">PMC7387429</ArticleId><ArticleId IdType="pubmed">32793182</ArticleId></ArticleIdList></Reference><Reference><Citation>Flud V.V., Shcherbuk Y.A., Shcherbuk A.Y., Leonov V.I., Al-Sahli O.A. Neurological complications and consequences of new coronavirus COVID-19 infection in elderly and old patients. Adv. Gerontol. 2022;35:231&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pubmed">35727930</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Rivas J., Croce G., Muscat M., Weigt M. Epistatic models predict mutable sites in SARS-CoV-2 proteins and epitopes. Proc. Natl. Acad. Sci. USA. 2022;119:e2113118119. doi: 10.1073/pnas.2113118119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2113118119</ArticleId><ArticleId IdType="pmc">PMC8795541</ArticleId><ArticleId IdType="pubmed">35022216</ArticleId></ArticleIdList></Reference><Reference><Citation>Visco V., Vitale C., Rispoli A., Izzo C., Virtuoso N., Ferruzzi G.J., Santopietro M., Melfi A., Rusciano M.R., Maglio A., et al. Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems. J. Clin. Med. 2022;11:524. doi: 10.3390/jcm11030524.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11030524</ArticleId><ArticleId IdType="pmc">PMC8836767</ArticleId><ArticleId IdType="pubmed">35159974</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke Z., Oton J., Qu K., Cortese M., Zila V., McKeane L., Nakane T., Zivanov J., Neufeldt C.J., Cerikan B., et al. Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Nature. 2020;588:498&#x2013;502. doi: 10.1038/s41586-020-2665-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2665-2</ArticleId><ArticleId IdType="pmc">PMC7116492</ArticleId><ArticleId IdType="pubmed">32805734</ArticleId></ArticleIdList></Reference><Reference><Citation>Sah R., Rodriguez-Morales A.J., Jha R., Chu D.K.W., Gu H., Peiris M., Bastola A., Lal B.K., Ojha H.C., Rabaan A.A., et al. Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal. Microbiol. Resour. Announc. 2020;9:e169&#x2013;e220. doi: 10.1128/MRA.00169-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MRA.00169-20</ArticleId><ArticleId IdType="pmc">PMC7067954</ArticleId><ArticleId IdType="pubmed">32165386</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukiw W.J. Recent Advances in Our Molecular and Mechanistic Understanding of Misfolded Cellular Proteins in Alzheimer&#x2019;s Disease (AD) and Prion Disease (PrD) Biomolecules. 2022;12:166. doi: 10.3390/biom12020166.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12020166</ArticleId><ArticleId IdType="pmc">PMC8961532</ArticleId><ArticleId IdType="pubmed">35204666</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W., Tian J.-H., Pei Y.-Y., et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265&#x2013;269. doi: 10.1038/s41586-020-2008-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2008-3</ArticleId><ArticleId IdType="pmc">PMC7094943</ArticleId><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Lukiw W.J. SARS-CoV-2 Neuroinvasion, Inflammatory Neurodegeneration and Alzheimer&#x2019;s Disease. Front. Cell. Neurosci. 2022;16:937961. doi: 10.3389/fncel.2022.937961.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2022.937961</ArticleId><ArticleId IdType="pmc">PMC9247146</ArticleId><ArticleId IdType="pubmed">35783095</ArticleId></ArticleIdList></Reference><Reference><Citation>Tetz G., Tetz V. Prion-like Domains in Spike Protein of SARS-CoV-2 Differ across Its Variants and Enable Changes in Affinity to ACE2. Microorganisms. 2022;10:280. doi: 10.3390/microorganisms10020280.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms10020280</ArticleId><ArticleId IdType="pmc">PMC8878784</ArticleId><ArticleId IdType="pubmed">35208734</ArticleId></ArticleIdList></Reference><Reference><Citation>Letarov A.V., Babenko V.V., Kulikov E.E. Free SARS-CoV-2 Spike Protein S1 Particles May Play a Role in the Pathogenesis of COVID-19 Infection. Biochemistry. 2020;86:257&#x2013;261. doi: 10.1134/S0006297921030032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297921030032</ArticleId><ArticleId IdType="pmc">PMC7772528</ArticleId><ArticleId IdType="pubmed">33838638</ArticleId></ArticleIdList></Reference><Reference><Citation>Actis G.C., Ribaldone D.G., Pellicano R. COVID vaccine&#x2019;s hot problems: Erratic serious blood clotting, ill-defined pri-on-like reactogenicity of the spike, unclear roles of other factors. Minerva Med. 2021;112:695&#x2013;697. doi: 10.23736/S0026-4806.21.07769-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0026-4806.21.07769-7</ArticleId><ArticleId IdType="pubmed">35168305</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai L., Gao G.F. Viral targets for vaccines against COVID-19. Nat. Rev. Immunol. 2021;21:73&#x2013;82. doi: 10.1038/s41577-020-00480-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-00480-0</ArticleId><ArticleId IdType="pmc">PMC7747004</ArticleId><ArticleId IdType="pubmed">33340022</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll J.A., Chesebro B. Neuroinflammation, Microglia, and Cell-Association during Prion Disease. Viruses. 2019;11:65. doi: 10.3390/v11010065.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11010065</ArticleId><ArticleId IdType="pmc">PMC6356204</ArticleId><ArticleId IdType="pubmed">30650564</ArticleId></ArticleIdList></Reference><Reference><Citation>Baazaoui N., Iqbal K. COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences. J. Alzheimer&#x2019;s Dis. 2022;88:399&#x2013;416. doi: 10.3233/JAD-220105.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-220105</ArticleId><ArticleId IdType="pubmed">35599487</ArticleId></ArticleIdList></Reference><Reference><Citation>Geschwind M.D. Prion diseases. Contin. Minneap Minn. 2015;21:1612&#x2013;1638. doi: 10.1212/CON.0000000000000251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CON.0000000000000251</ArticleId><ArticleId IdType="pmc">PMC4879966</ArticleId><ArticleId IdType="pubmed">26633779</ArticleId></ArticleIdList></Reference><Reference><Citation>Candelise N., Scaricamazza S., Salvatori I., Ferri A., Valle C., Manganelli V., Garofalo T., Sorice M., Misasi R. Protein Aggregation Landscape in Neurodegenerative Diseases: Clinical Relevance and Future Applications. Int. J. Mol. Sci. 2021;22:6016. doi: 10.3390/ijms22116016.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22116016</ArticleId><ArticleId IdType="pmc">PMC8199687</ArticleId><ArticleId IdType="pubmed">34199513</ArticleId></ArticleIdList></Reference><Reference><Citation>Wulf M.-A., Senatore A., Aguzzi A., Wulf M.-A., Senatore A., Aguzzi A. The biological function of the cellular prion pro-tein: An update. BMC Biol. 2017;15:1&#x2013;13. doi: 10.1186/s12915-017-0375-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12915-017-0375-5</ArticleId><ArticleId IdType="pmc">PMC5412054</ArticleId><ArticleId IdType="pubmed">28464931</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto C., Satani N. The intricate mechanisms of neurodegeneration in prion diseases. Trends Mol. Med. 2011;17:14&#x2013;24. doi: 10.1016/j.molmed.2010.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2010.09.001</ArticleId><ArticleId IdType="pmc">PMC3056171</ArticleId><ArticleId IdType="pubmed">20889378</ArticleId></ArticleIdList></Reference><Reference><Citation>Young M.J., O&#x2019;Hare M., Matiello M., Schmahmann J.D. Creutzfeldt-Jakob disease in a man with COVID-19: SARS-CoV-2-accelerated neurodegeneration? Brain Behav Immun. 2020;89:601&#x2013;603. doi: 10.1016/j.bbi.2020.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.07.007</ArticleId><ArticleId IdType="pmc">PMC7362815</ArticleId><ArticleId IdType="pubmed">32681865</ArticleId></ArticleIdList></Reference><Reference><Citation>Beretta S., Stabile A., Balducci C., DiFrancesco J.C., Patruno A., Rona R., Bombino M., Capraro C., Andreetta F., Cavalcante P., et al. COVID-19-associated immune-mediated encephalitis mimicking acute-onset Creutzfeldt-Jakob disease. Ann. Clin. Transl. Neurol. 2021;8:2314&#x2013;2318. doi: 10.1002/acn3.51479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51479</ArticleId><ArticleId IdType="pmc">PMC8670319</ArticleId><ArticleId IdType="pubmed">34825771</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuvand&#x131;k A., &#xd6;zcan E., Karaduman S., Sungurtekin H. Creutzfeldt-Jakob Disease After the Coronavirus Disease-2019 Vaccination. Turk. J. Intensiv. Care. 2021;20:61&#x2013;64. doi: 10.4274/tybd.galenos.2021.91885.</Citation><ArticleIdList><ArticleId IdType="doi">10.4274/tybd.galenos.2021.91885</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciolac D., Racila R., Duarte C., Vasilieva M., Manea D., Gorincioi N., Condrea A., Crivorucica I., Zota E., Efremova D., et al. Clinical and Radiological Deterioration in a Case of Creutzfeldt&#x2013;Jakob Disease following SARS-CoV-2 Infection: Hints to Accelerated Age-Dependent Neurodegeneration. Biomedicines. 2021;9:1730. doi: 10.3390/biomedicines9111730.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9111730</ArticleId><ArticleId IdType="pmc">PMC8615966</ArticleId><ArticleId IdType="pubmed">34829958</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernardini A., Gigli G.L., Janes F., Pellitteri G., Ciardi C., Fabris M., Valente M. Creutzfeldt-Jakob disease after COVID-19: Infection-induced prion protein misfolding? A case report. Prion. 2022;16:78&#x2013;83. doi: 10.1080/19336896.2022.2095185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2022.2095185</ArticleId><ArticleId IdType="pmc">PMC9255144</ArticleId><ArticleId IdType="pubmed">35786166</ArticleId></ArticleIdList></Reference><Reference><Citation>Burwinkel M., Riemer C., Schwarz A., Schultz J., Neidhold S., Bamme T., Baier M. Role of cytokines and chemokines in prion infections of the central nervous system. Int. J. Dev. Neurosci. 2004;22:497&#x2013;505. doi: 10.1016/j.ijdevneu.2004.07.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijdevneu.2004.07.017</ArticleId><ArticleId IdType="pubmed">15465279</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivo S., Furlanis G., Stella A.B., Fabris M., Milanic R., Zanusso G., Manganotti P. Rapidly evolving Creutzfeldt&#x2013;Jakob disease in COVID-19: From early status epilepticus to fatal outcome. Acta Neurol. Belg. 2022:1&#x2013;4. doi: 10.1007/s13760-022-02023-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-022-02023-x</ArticleId><ArticleId IdType="pmc">PMC9294798</ArticleId><ArticleId IdType="pubmed">35852764</ArticleId></ArticleIdList></Reference><Reference><Citation>Manosso L., Arent C., Borba L., Ceretta L., Quevedo J., R&#xe9;us G. Microbiota-Gut-Brain Communication in the SARS-CoV-2 Infection. Cells. 2021;10:1993. doi: 10.3390/cells10081993.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10081993</ArticleId><ArticleId IdType="pmc">PMC8391332</ArticleId><ArticleId IdType="pubmed">34440767</ArticleId></ArticleIdList></Reference><Reference><Citation>Paiardi G., Richter S., Oreste P., Urbinati C., Rusnati M., Wade R.C. The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms. J. Biol. Chem. 2022;298:101507. doi: 10.1016/j.jbc.2021.101507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.101507</ArticleId><ArticleId IdType="pmc">PMC8683219</ArticleId><ArticleId IdType="pubmed">34929169</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahzad S., Willcox M. The Possible Role of Prion-Like Viral Protein Domains on the Emergence of Novel Viruses as SARS-CoV-2. J. Mol. Evol. 2022;90:227&#x2013;230. doi: 10.1007/s00239-022-10054-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00239-022-10054-4</ArticleId><ArticleId IdType="pmc">PMC8972983</ArticleId><ArticleId IdType="pubmed">35362781</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E., Zhang C., Israelow B., Lu-Culligan A., Prado A.V., Skriabine S., Lu P., Weizman O.-E., Liu F., Dai Y., et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J. Exp. Med. 2021;218:e20202135. doi: 10.1084/jem.20202135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202135</ArticleId><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C.-Y., Chen Y.-H., Liu P.-J., Hu W.-C., Lu K.-C., Tsai K.-W. The emerging role of miRNAs in the pathogenesis of COVID-19: Protective effects of nutraceutical polyphenolic compounds against SARS-CoV-2 infection. Int. J. Med Sci. 2022;19:1340&#x2013;1356. doi: 10.7150/ijms.76168.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.76168</ArticleId><ArticleId IdType="pmc">PMC9346380</ArticleId><ArticleId IdType="pubmed">35928726</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh Y.C., Doan L.H., Huang Z.Y., Chu L.W., Shi T.H., Lee Y.R., Wu C.T., Lin C.H., Chiang S.T., Liu H.K., et al. Honeysuckle (Lonicera japonica) and Huangqi (Astragalus membranaceus) suppress SARS-CoV-2 entry and COVID-19 related cytokine storm in vitro. Front Pharmacol. 2022;12:765553. doi: 10.3389/fphar.2021.765553.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.765553</ArticleId><ArticleId IdType="pmc">PMC8990830</ArticleId><ArticleId IdType="pubmed">35401158</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexandrov P.N., Dua P., Lukiw W.J. Up-Regulation of miRNA-146a in Progressive, Age-Related Inflammatory Neurodegenerative Disorders of the Human CNS. Front. Neurol. 2014;5:181. doi: 10.3389/fneur.2014.00181.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2014.00181</ArticleId><ArticleId IdType="pmc">PMC4179622</ArticleId><ArticleId IdType="pubmed">25324823</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Jaber V., Alexandrov P.N., Vergallo A., Lista S., Hampel H., Lukiw W.J. microRNA-Based Biomarkers in Alzheimer&#x2019;s Disease (AD) Front. Neurosci. 2020;14:585432. doi: 10.3389/fnins.2020.585432.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.585432</ArticleId><ArticleId IdType="pmc">PMC7664832</ArticleId><ArticleId IdType="pubmed">33192270</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill J.M., Clement C., Zhao Y., Lukiw W.J. Induction of the pro-inflammatory NF-kB-sensitive miRNA-146a by human neurotrophic viruses. Front. Microbiol. 2015;6:43. doi: 10.3389/fmicb.2015.00043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2015.00043</ArticleId><ArticleId IdType="pmc">PMC4315103</ArticleId><ArticleId IdType="pubmed">25691883</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukiw W.J. microRNA-146a Signaling in Alzheimer&#x2019;s Disease (AD) and Prion Disease (PrD) Front. Neurol. 2020;11:462. doi: 10.3389/fneur.2020.00462.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00462</ArticleId><ArticleId IdType="pmc">PMC7331828</ArticleId><ArticleId IdType="pubmed">32670176</ArticleId></ArticleIdList></Reference><Reference><Citation>Roganovi&#x107; J.R. microRNA-146a and -155, upregulated by periodontitis and type 2 diabetes in oral fluids, are predicted to regulate SARS-CoV-2 oral receptor genes. J. Periodontol. 2021;92:35&#x2013;43. doi: 10.1002/JPER.20-0623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JPER.20-0623</ArticleId><ArticleId IdType="pubmed">33336412</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinacchio C., Scordio M., Santinelli L., Frasca F., Sorrentino L., Bitossi C., Oliveto G., Viscido A., Ceci F.M., Celani L., et al. Analysis of serum microRNAs and rs2910164 GC single-nucleotide polymorphism of miRNA-146a in COVID-19 patients. J. Immunoass. Immunochem. 2022;43:347&#x2013;364. doi: 10.1080/15321819.2022.2035394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15321819.2022.2035394</ArticleId><ArticleId IdType="pubmed">35227165</ArticleId></ArticleIdList></Reference><Reference><Citation>Hascup E.R., Hascup K.N. Does SARS-CoV-2 infection cause chronic neurological complications? GeroScience. 2020;42:1083&#x2013;1087. doi: 10.1007/s11357-020-00207-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-020-00207-y</ArticleId><ArticleId IdType="pmc">PMC7247778</ArticleId><ArticleId IdType="pubmed">32451846</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu C., Chen C., Dong X.-P. Impact of COVID-19 Pandemic on Patients With Neurodegenerative Diseases. Front. Aging Neurosci. 2021;13:664965. doi: 10.3389/fnagi.2021.664965.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.664965</ArticleId><ArticleId IdType="pmc">PMC8060506</ArticleId><ArticleId IdType="pubmed">33897410</ArticleId></ArticleIdList></Reference><Reference><Citation>Tayyebi G., Malakouti S.K., Shariati B., Kamalzadeh L. COVID-19-associated encephalitis or Creutzfeldt&#x2013;Jakob disease: A case report. Neurodegener. Dis. Manag. 2022;12:29&#x2013;34. doi: 10.2217/nmt-2021-0025.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nmt-2021-0025</ArticleId><ArticleId IdType="pmc">PMC8765092</ArticleId><ArticleId IdType="pubmed">34854312</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>